Vikas Sinha is Executive Vice President, Chief Financial Officer of Alexion Pharmaceuticals, with responsibility for global financial management, corporate & strategic development, treasury, internal audit, investor relations, information technology, engineering, and real estate & security activities. Mr. Sinha has built these functions since 2005, when Alexion was based only in the US and had no approved product for sale.
Today, he leads global teams working in more than 20 countries to support the launches of Soliris in PNH and aHUS while building out Alexion’s global capabilities to support additional indications for Soliris and the launch of new transformative therapeutic candidates resulting from both internal development and strategic acquisitions.
Prior to joining Alexion, Mr. Sinha spent 11 years with Bayer AG in the US, Japan, Germany and Canada, rising to the position of Vice President and CFO of the Bayer Pharmaceutical organization in Japan and later, the US. Prior to Bayer, Mr. Sinha also held several positions of increasing responsibility with ANZ Bank and Citibank in South Asia.
Mr. Sinha holds a master's degree in business administration from the Asian Institute of Management. He is also a qualified Chartered Accountant from the Institute of Chartered Accountants of India and a Certified Public Accountant in the US.